Molecular architecture and catalytic mechanism of human glycogen debranching enzyme [PDF]
Glycogen, a key branched glucose polymer, acts as a vital energy reservoir in mammalian cells, particularly during intense activity or fasting. The glycogen debranching enzyme (GDE) plays a key role in glycogen degradation by removing branches, ensuring ...
Huiyi Guan +7 more
doaj +5 more sources
Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease. [PDF]
Bladder cancer is the most common malignancy of the urinary system, yet our molecular understanding of this disease is incomplete, hampering therapeutic advances.Here we used a genome-wide functional short-hairpin RNA (shRNA) screen to identify suppressors of in vivo bladder tumor xenograft growth (n = 50) using bladder cancer UMUC3 cells.
Guin S +16 more
europepmc +5 more sources
Crystal structure of glycogen debranching enzyme and insights into its catalysis and disease-causing mutations [PDF]
Debranching of glycogen is an important step in its use as an energy source. Here, the authors describe the crystal structures of glycogen debranching enzyme alone and in complex with oligosaccharides and provide molecular insights into the function, and
Liting Zhai +4 more
doaj +4 more sources
A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme [PDF]
Glycogen storage disease type III (GSD III) is an inherited disorder caused by a deficiency of glycogen debranching enzyme (GDE), which results in the accumulation of abnormal glycogen (limit dextrin) in the cytoplasm of liver, heart, and skeletal muscle
Jeong-A Lim +4 more
doaj +4 more sources
Involvement of glycogen debranching enzyme in bladder cancer. [PDF]
Bladder cancer is the most common malignancy of the urinary system, however the molecular pathways underlying this disease are incompletely understood. To understand new regulators of bladder cancer progression, the authors carried out a functional genomic screen which identified glycogen debranching enzyme (AGL) as a novel regulator of bladder cancer ...
Weinhaus B, Guin S.
europepmc +6 more sources
Crystal structures of glycogen-debranching enzyme mutants in complex with oligosaccharides. [PDF]
Debranching is a critical step in the mobilization of the important energy store glycogen. In eukaryotes, including fungi and animals, the highly conserved glycogen-debranching enzyme (GDE) debranches glycogen by a glucanotransferase (GT) reaction followed by a glucosidase (GC) reaction. Previous work indicated that these reactions are catalyzed by two
Shen M, Gong X, Xiang S.
europepmc +5 more sources
Physical exercise intervention in glycogen storage disease IIIa: Feasibility and multisystem benefits [PDF]
Glycogen storage disease III (GSD‐III) is caused by an inherited deficiency of the glycogen debranching enzyme. Affecting the liver, muscle and heart, GSD‐IIIa is the most common GSD‐III subtype.
Asunción Bustos‐Sellers +14 more
doaj +3 more sources
Identification of the Catalytic Residues of Bifunctional Glycogen Debranching Enzyme [PDF]
Eukaryotic glycogen debranching enzyme (GDE) possesses two different catalytic activities (oligo-1,4-->1,4-glucantransferase/amylo-1,6-glucosidase) on a single polypeptide chain. To elucidate the structure-function relationship of GDE, the catalytic residues of yeast GDE were determined by site-directed mutagenesis. Asp-535, Glu-564, and Asp-670 on the
Akifumi Nakayama +2 more
openalex +4 more sources
Mono-(2-ethylhexyl) phthalate Targets Glycogen Debranching Enzyme and Affects Glycogen Metabolism in Rat Testis [PDF]
Phthalate esters are commonly used plasticizers; however, some are suspected to cause reproductive toxicity. Administration of high doses of di-(2-ethylhexyl) phthalate (DEHP) induces germ cell death in male rodents. Mono-(2-ethylhexyl) phthalate (MEHP), a hydrolyzed metabolite of DEHP, appears to be responsible for this testicular toxicity; however ...
Chikanori Kuramori +13 more
openalex +3 more sources
Glycogen Storage Disease in Twins: When Two Lives Reflect One Silent Battle. [PDF]
ABSTRACT Early recognition of hepatomegaly, hypoglycemia, and elevated liver enzymes in infants is crucial for diagnosing glycogen storage disease. Liver biopsy with PAS–diastase staining provides definitive confirmation. Prompt metabolic management and regular follow‐up are essential to prevent progression of fibrosis and long‐term hepatic ...
Shah RK +10 more
europepmc +2 more sources

